CliffBio
small molecule

QUILLIVANT XR

METHYLPHENIDATE HYDROCHLORIDE

Loss of exclusivityFebruary 2031latest FDA-listed patent expiry
CompanyNEXTWAVE PHARMACEUTICALS INC A SUB OF TRIS PHARMA INC

Drug detail

Brand nameQUILLIVANT XR
Active ingredientMETHYLPHENIDATE HYDROCHLORIDE
Strength5MG/ML
Dosage formFOR SUSPENSION, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalSeptember 2012
Marketing statusRX

Listed patents

PatentExpiresType
8563033February 2031product
8778390February 2031product
8956649February 2031product
8465765February 2031product
9040083February 2031product
8287903February 2031product
8062667March 2029product

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.